OVARIANCANCER

Clinical trials for OVARIANCANCER explained in plain language.

Never miss a new study

Get alerted when new OVARIANCANCER trials appear

Sign up with your email to follow new studies for OVARIANCANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to shrink ovarian tumors in 30-Patient trial

Disease control Not yet recruiting

This study tests whether combining two drugs, zeprumetostat and fuzuloparib, can shrink tumors in people with advanced or recurrent ovarian cancer. About 30 adults aged 18-75 with a specific genetic profile (BRCA1/2 wild-type) will take part. The main goal is to see how many pati…

Matched conditions: OVARIANCANCER

Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated May 17, 2026 04:34 UTC

OVARIANCANCER

Get alerted when new OVARIANCANCER trials appear

New drug combo aims to shrink ovarian tumors in 30-Patient trial